High-level expression of glycoprotein D by a dominant-negative HSV-1 virus augments its efficacy as a vaccine against HSV-1 infection.
about
Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs.A herpes simplex virus 2 (HSV-2) glycoprotein D-expressing nonreplicating dominant-negative HSV-2 virus vaccine is superior to a gD2 subunit vaccine against HSV-2 genital infection in guinea pigsAn attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challengeA Highly Efficacious Herpes Simplex Virus 1 Vaccine Blocks Viral Pathogenesis and Prevents Corneal Immunopathology via Humoral ImmunityDevelopment of a glycoprotein D-expressing dominant-negative and replication-defective herpes simplex virus 2 (HSV-2) recombinant viral vaccine against HSV-2 infection in miceImmunization with a highly attenuated replication-competent herpes simplex virus type 1 mutant, HF10, protects mice from genital disease caused by herpes simplex virus type 2Comparison of the host immune response to herpes simplex virus 1 (HSV-1) and HSV-2 at two different mucosal sites.The challenge of developing a herpes simplex virus 2 vaccine.Prevention of genital herpes simplex virus type 1 and 2 disease in mice immunized with a gD-expressing dominant-negative recombinant HSV-1.HSV Recombinant Vectors for Gene Therapy.Expression and immunogenicity of recombinant glycoprotein D of herpes simplex virus 1 in Drosophila S2 cells.
P2860
Q33595097-2F7E6145-004A-49B8-8373-26B7223E1180Q33825931-98AF6D5B-E065-4E46-9051-1FFAACB7FF8FQ33916162-F98042E1-8173-44BD-891C-92FF73D7B9DFQ34520389-2CEEC4BF-FA42-42A3-BDA2-1FE5B7194656Q35076638-D5D2B870-442C-433D-9A56-634A72F2B315Q35920203-7CDE9EB2-3E20-49BE-BF7B-4725752580E4Q36155593-1281394E-E43B-424A-9ECE-3A55FE67B12BQ36671106-5DE04114-3B4C-4943-A4AA-4AFC33E44CC9Q37450218-320EC693-3281-42E5-9525-4D5C4E2A3706Q37787777-5708C263-F3D0-4711-908F-5E8FE440DE52Q40032768-DFF9AF2E-26F0-4D4E-8C7E-F9C120BB2A91
P2860
High-level expression of glycoprotein D by a dominant-negative HSV-1 virus augments its efficacy as a vaccine against HSV-1 infection.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
High-level expression of glyco ...... ccine against HSV-1 infection.
@en
High-level expression of glyco ...... ccine against HSV-1 infection.
@nl
type
label
High-level expression of glyco ...... ccine against HSV-1 infection.
@en
High-level expression of glyco ...... ccine against HSV-1 infection.
@nl
prefLabel
High-level expression of glyco ...... ccine against HSV-1 infection.
@en
High-level expression of glyco ...... ccine against HSV-1 infection.
@nl
P2093
P2860
P356
P1476
High-level expression of glyco ...... ccine against HSV-1 infection.
@en
P2093
Nao Murakami
Natali V Akhrameyeva
Richard Brans
Zheming Lu
P2860
P2888
P304
P356
10.1038/JID.2008.349
P407
P577
2008-11-13T00:00:00Z